Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of Patient-Derived Xenografts

ABSTRACT: RNA sequencing of Patient-Derived Xenografts

PROVIDER: PRJNA1026533 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26337500.fastq.gz	Fastqsanger.gz
	SRR26337501.fastq.gz	Fastqsanger.gz
	SRR26337502.fastq.gz	Fastqsanger.gz
	SRR26337503.fastq.gz	Fastqsanger.gz
	SRR26337504.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 19

Similar Datasets

Thoracic patient-derived xenografts

Project description:Thoracic patient-derived xenografts

| PRJNA339191 | ENA

RNA sequencing of patient-derived AML xenografts treated with Fedratinib

Project description:RNA sequencing of patient-derived AML xenografts treated with Fedratinib

| PRJNA820019 | ENA

RNA sequencing of patient-derived AML xenografts treated with Selinexor (KPT-330)

Project description:RNA sequencing of patient-derived AML xenografts treated with Selinexor (KPT-330)

| PRJNA820015 | ENA

RNA sequencing data from triple-negative breast cancer patient-derived xenografts (PDX)

Project description:RNA sequencing data from triple-negative breast cancer patient-derived xenografts (PDX)

| PRJNA434130 | ENA

Sequencing of patient-derived xenografts in NSG mice

Project description:Variant analysis of patient-derived xenografts in NSG mice

| PRJEB52345 | ENA

RNA-seq of prostate cancer Patient‐Derived Xenografts derived from primary and metastatic tumors at different stages of progression

Project description:Patient-Derived Xenografts from primary (PNPCa) and metastatic (LuCaP series) prostate tumors have been implanted in immunocompromised mice and then subjected to PolyA+ RNA-sequencing.

2020-12-10 | E-MTAB-9656 | biostudies-arrayexpress

RNA seq analysis of LuCaP Prostate Cancer Patient-Derived Xenografts

Project description:RNA seq analysis of LuCaP Prostate Cancer Patient-Derived Xenografts

| PRJNA764660 | ENA

Patient-derived Human Breast Cancer Xenografts

Project description:Breast cancer research is hampered by difficulties in obtaining and studying primary human breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology accurately. To overcome these limitations, we propagated a cohort of human breast tumors grown in the epithelium-free mammary fat pad of SCID/Beige and NOD/SCID/IL2γ-receptor null (NSG) mice, under a series of transplant conditions. Both models yielded stably transplantable xenografts at comparably high rates (~23% and ~19%, respectively). Of the conditions tested, xenograft take rate was highest in the presence of a low-dose estradiol pellet. Overall, 32 stably transplantable xenograft lines were established, representing unique 25 patients. Most tumors yielding xenografts were “triple-negative” (ER-PR-HER2+) (n=19). However, we established lines from three ER-PR-HER2+ tumors, one ER+PR-HER2-, one ER+PR+HER2- and one “triple-positive” (ER+PR+HER2+) tumor. Serially passaged xenografts show biological consistency with the tumor of origin, are phenotypic stability across multiple transplant generations at the histological, transcriptomic, proteomic, and genomic levels, and show comparable treatment responses. Xenografts representing 12 patients, including two ER+ lines, showed metastasis to the mouse lung. These models thus serve as a renewable, quality-controlled tissue resource for preclinical studies investigating treatment response and metastasis. The study was designed to determine how stable patient-derived xenografts are across multiple transplant generations in mice, and to determine how closely xenografts established with pre-treatment samples cluster with xenografts established with post-treatment samples. Overall, pre-treatment and post-treatment samples derived from the same patient cluster together, and multiple transplant generations of xenografts derived from an individual patient cluster together.

2013-05-30 | E-GEOD-46106 | biostudies-arrayexpress

RNA sequencing of Patient-Derived Xenografts

Project description:Goal: Comparison of mRNA expression profiles in patient-derived xenograft primary tumors Methods: RNA sequencing performed at the High-Throughput Genomics and Bioinformatics Analysis Core at the University of Utah. Detailed procedures available in methods and DNA processing pipline sections. Results: Focus of study compared mRNA expression profiles of samples pre and post passaging in vivo. Unsupervised heirarchical clustering revealed samples clustered together appropriately. Conclusions: The PDX maintain the gene expression profiles of the original tumor.

2023-10-10 | GSE244967 | GEO

scRNA-seq of pediatric glioblastoma patient-derived xenografts

Project description:scRNA-seq of patient-derived xenografts.

2019-03-15 | GSE117599 | GEO